Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Boston Scientific (BSX) Any Comments??? -- Ignore unavailable to you. Want to Upgrade?

To: yard_man who wrote (508)	9/30/1998 5:35:00 PM
From: John Carragher	Read Replies (1) \| Respond to of 798

here's the stent info. FDA Clears Boston Scientific Coronary Stent Pdt Dow Jones Newswires NATICK, Mass. -- Boston Scientific Corp. (BSX) received approval from the Food and Drug Administration for its Magic Wallstent to treat coronary artery disease. In a press release Wednesday, Boston Scientific said it plans to launch the Magic Wallstent in the U.S. in the fourth quarter. The Magic Wallstent will be available to treat lesion lengths up to 35 millimeters and covers vessel diameters of 3.0 millimeters to 5.5 millimeters, the manufacturer of medical devices said.